ES482004A1 - Procedimiento para la preparacion de nuevos derivados 5-fe- nilpirazolicos. - Google Patents

Procedimiento para la preparacion de nuevos derivados 5-fe- nilpirazolicos.

Info

Publication number
ES482004A1
ES482004A1 ES482004A ES482004A ES482004A1 ES 482004 A1 ES482004 A1 ES 482004A1 ES 482004 A ES482004 A ES 482004A ES 482004 A ES482004 A ES 482004A ES 482004 A1 ES482004 A1 ES 482004A1
Authority
ES
Spain
Prior art keywords
phenyl
preparation
salts
processes
pyrazole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES482004A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Kali Chemie Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma GmbH filed Critical Kali Chemie Pharma GmbH
Publication of ES482004A1 publication Critical patent/ES482004A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procedimiento para la preparación de nuevos derivados 5- fenilpirazólicos de la fórmula I **(Fórmula)** en donde R1 y R2 pueden ser iguales o diferentes y significan u átomo de hidrógeno o de cloro o un grupo trifluorometilo, R3 es un átomo de hidrógeno, un radical fenilo, bencilo o alcohilo con 1 hasta 6 átomos de carbono, que puede ser de cadena recta, ramificado o cíclico, R4 es un átomo de hidrógeno o radical metilo, R5 es un radical alcohilo con 1 hasta 4 átomos de carbono, de cadena recta o ramificado, y A es carboxilo, así como las sales farmacológicamente compatibles de los ácidos.
ES482004A 1978-06-29 1979-06-28 Procedimiento para la preparacion de nuevos derivados 5-fe- nilpirazolicos. Expired ES482004A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782828529 DE2828529A1 (de) 1978-06-29 1978-06-29 Neue 5-phenylpyrazol-derivate, verfahren zu deren herstellung und arzneimittel

Publications (1)

Publication Number Publication Date
ES482004A1 true ES482004A1 (es) 1980-03-01

Family

ID=6043086

Family Applications (2)

Application Number Title Priority Date Filing Date
ES482004A Expired ES482004A1 (es) 1978-06-29 1979-06-28 Procedimiento para la preparacion de nuevos derivados 5-fe- nilpirazolicos.
ES482002A Expired ES482002A1 (es) 1978-06-29 1979-06-28 Procedimiento para la preparacion de nuevos derivados 5-fe- nilpirazolicos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES482002A Expired ES482002A1 (es) 1978-06-29 1979-06-28 Procedimiento para la preparacion de nuevos derivados 5-fe- nilpirazolicos.

Country Status (6)

Country Link
EP (1) EP0007019A1 (es)
JP (1) JPS559078A (es)
DE (1) DE2828529A1 (es)
DK (1) DK273479A (es)
ES (2) ES482004A1 (es)
PT (1) PT69821A (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3132915A1 (de) * 1981-08-20 1983-03-03 Kali-Chemie Pharma Gmbh, 3000 Hannover 1,5-diphenylpyrazolin-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2513996A1 (fr) * 1981-10-02 1983-04-08 Nativelle Sa Ets Derives du pyrazole, procede pour leur preparation et application en therapeutique
FR2529786A1 (fr) * 1982-07-12 1984-01-13 Nativelle Sa Ets Compositions pharmaceutiques a base de derives de la pyrazolone-5, nouveaux produits et procede de preparation
US4550119A (en) * 1983-05-23 1985-10-29 Warner-Lambert Company 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones
DE3424586A1 (de) * 1984-07-04 1986-01-09 Kali-Chemie Pharma Gmbh, 3000 Hannover 3-aminocarbonylmethoxy-5-phenyl-pyrazol-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2659655B1 (fr) * 1990-03-19 1992-07-24 Union Pharma Scient Appl Nouveaux derives d'oxypyrazole antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.
US5547967A (en) * 1993-12-08 1996-08-20 Kali-Chemie Pharma Gmbh (Phenylalkylaminoalkyloxy)-heteroaryl-compounds, processes and intermediates for their production and pharmaceutical compositions containing them
DE4341749A1 (de) * 1993-12-08 1995-06-14 Kali Chemie Pharma Gmbh 3-(Phenylalkylaminoalkyloxy)-5-phenylpyrazol- Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2773153A1 (fr) * 1997-12-29 1999-07-02 Rhone Poulenc Agrochimie Nouveaux composes fongicides
CN102093344B (zh) * 2011-03-17 2012-09-26 南京工业大学 一种含噻唑硫酮或噁唑烷酮的n-取代乙酰氧吡唑类化合物、制备方法及用途
CA3142286A1 (en) 2019-06-03 2020-12-10 Bayer Aktiengesellschaft 1-phenyl-5-azinyl pyrazolyl-3-oxyalkyl acids and their use for controlling undesired plant growth
HUE063556T2 (hu) 2019-11-26 2024-01-28 Bayer Ag [(1,5-difenil-1H-1,2,4-triazol-3-il)oxi]ecetsav-származékok és ezek sói, ezeket tartalmazó növényvédõszer haszon- vagy kultúrnövényekhez, eljárás ezek elõállítására és alkalmazásuk széfenerként
EP4075979A1 (de) 2019-12-19 2022-10-26 Bayer Aktiengesellschaft 1,5-diphenylpyrazolyl-3-oxyalkylsäuren und 1-phenyl-5-thienylpyrazolyl-3-oxyalkylsäuren und deren verwendung zur bekämpfung unerwünschten pflanzenwachstums
WO2021219527A1 (de) 2020-04-29 2021-11-04 Bayer Aktiengesellschaft 1-pyrazinylpyrazolyl-3-oxyalkylsäuren sowie deren derivate und deren verwendung zur bekämpfung unerwünschten pflanzenwachstums
MX2023004617A (es) * 2020-10-23 2023-05-09 Bayer Ag Derivados de 1-(piridil)-5-azinilpirazol y su uso para el combate del crecimiento de plantas no deseado.
WO2022096450A1 (de) 2020-11-05 2022-05-12 Bayer Aktiengesellschaft Verwendung von [(1,5-diphenyl-1h-pyrazol-3-yl)oxy]essigsäure-derivaten und deren salze sowie diese enthaltende mittel, zur reduktion phytotoxischer wirkungen von agrochemikalien, insbesondere von herbiziden, in nutz- oder kulturpflanzen.
CA3200680A1 (en) 2020-11-05 2022-05-12 Bayer Aktiengesellschaft [(1-phenyl-5-heteroaryl-1h-pyrazol-3-yl)oxy] acetic acid derivatives as safeners for the protection of useful plants and crop plants
US12606542B2 (en) 2020-11-05 2026-04-21 Bayer Aktiengesellschaft [(1,5-diheteroaryl-1H-1,2,4-triazol-3-yl)oxy] acetic acid derivatives as safeners for the protection of useful plants and crop plants
US20240391862A1 (en) 2021-06-25 2024-11-28 Bayer Aktiengesellschaft (1,4,5-trisubstituted-1h-pyrazol-3-yl)oxy-2-alkoxy alkyl acids and their derivatives, their salts and their use as herbicidal agents
JP2024542693A (ja) 2021-12-01 2024-11-15 バイエル・アクチエンゲゼルシヤフト （１，４，５－三置換－１ｈ－ピラゾール－３－イル）オキシ－２－アルコキシチオアルキル酸およびその誘導体、その塩ならびに除草活性剤としてのその使用
WO2024078871A1 (de) 2022-10-14 2024-04-18 Bayer Aktiengesellschaft 1-pyridyl-5-phenylpyrazolyl-3-oxy- und -3-thioalkylsäuren und derivate und deren verwendung zur bekämpfung unerwünschten pflanzenwachstums

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2347015C2 (de) * 1973-09-14 1985-12-12 Schering AG, 1000 Berlin und 4709 Bergkamen Neue Pyrazolyloxyessigsäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
DD118638A1 (es) * 1975-04-10 1976-03-12
DD135487A2 (de) * 1977-03-14 1979-05-09 Helmut Dorn Verfahren zur herstellung neuer 3-(1-carboxy-alkoxy)-pyrazol-derivate
DE2809183C2 (de) * 1977-03-14 1984-12-06 Akademie Der Wissenschaften Der Ddr, Ddr 1199 Berlin 3-(1-Carboxy-alkoxy)-pyrazol-Derivate und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
EP0007019A1 (de) 1980-01-23
PT69821A (en) 1979-07-01
JPS559078A (en) 1980-01-22
ES482002A1 (es) 1980-03-01
DE2828529A1 (de) 1980-01-17
DK273479A (da) 1980-02-04

Similar Documents

Publication Publication Date Title
ES482004A1 (es) Procedimiento para la preparacion de nuevos derivados 5-fe- nilpirazolicos.
PH23739A (en) Piperidine derivative and pharmaceutical composition
IE832405L (en) 1-phenyl-2-piperidinoalkanols.
DK160877C (da) Fremgangsmaade til fremstilling af 2-penemforbindelser
AU561450B2 (en) 2-amino-3-acylamino-6-benzylamino pyridine derivatives
IL65801A (en) 1-substituted spiro-(piperidineoxobenzoxazine)s,their preparation and pharmaceutical compositions containing them
ES385635A1 (es) Procedimiento para la preparacion de n-alil-2-arilamino - imidazolinos-(2) sustituidas.
ES8507090A1 (es) Procedimiento para la obtencion de nuevas 1, 5-benzotiacepinas
IL66152A0 (en) Pyridinocarbinols,their preparation and their use as fungicides
IE790996L (en) Phenylaminothiophene derivatives
ES423232A1 (es) Procedimiento para la preparacion de nuevas 2-fenilamino-i-midazolinas-(2) sustituidas.
ES477878A1 (es) Un procedimiento para preparar mercaptoacilaminoacidos sustituidos con halogeno.
ES481700A1 (es) Un procedimiento para la preparacion de derivados de 1,3,5- triazacicloheptan-2,4-diona.
ES476355A1 (es) Procedimiento para la obtencion de nuevos derivados de ari- laminoimidazolina
IE812498L (en) Pyrimidine derivatives.
ES446325A1 (es) Procedimiento para preparar tieno-(3,2-c)-piridina y deriva-dos de la misma.
AU543289B2 (en) 3-thiovinylcephalosporins
ES8706623A1 (es) Procedimiento de preparar compuestos amidicos farmacologicamente activos
JPS5690067A (en) Novel heterocyclic ring substituted phenylacetic acid derivative
ES8203876A1 (es) Procedimiento de obtencion de nuevos a-amino derivados ci- clicos del 1-(3',4'-metilendioxifenil)etanol
ES417065A1 (es) Procedimiento para la preparacion de nuevos derivados de n-(triaril-metil)-amidina.
IL61695A (en) 2-(2,6-dihalophenyl-amino)-and 2-(2-fluoro-6-trifluoromethyl-phenyl-amino)-2-imidazoline derivatives,their preparation and pharmaceutical compositions containing them
ES443265A1 (es) Un procedimiento para preparar derivados de tiazolina.
DE2963679D1 (en) Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them
DE3260242D1 (en) 4-phenoxy-3-hydroxy-butyramidoxime derivatives, preparation thereof and use thereof as medicaments